Atlas Trials

Efficacy of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% BAK-Free Fixed Combination) From Prior Therapy

Clinical trial NCT01514721 · TERMINATED

Trial details

NCT number
NCT01514721
Sponsor
Alcon Research
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Glaucoma
Start date
2012-06-01
Primary completion
2013-11-01
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.